Activity

Filter

Cancel
Date Panel Item Activity
5 actions
Malignant Hyperthermia Susceptibility v1.3 ATP2A1 Bryony Thompson Marked gene: ATP2A1 as ready
Malignant Hyperthermia Susceptibility v1.3 ATP2A1 Bryony Thompson Gene: atp2a1 has been classified as Amber List (Moderate Evidence).
Malignant Hyperthermia Susceptibility v1.3 ATP2A1 Bryony Thompson Classified gene: ATP2A1 as Amber List (moderate evidence)
Malignant Hyperthermia Susceptibility v1.3 ATP2A1 Bryony Thompson Gene: atp2a1 has been classified as Amber List (Moderate Evidence).
Malignant Hyperthermia Susceptibility v1.2 ATP2A1 Bryony Thompson gene: ATP2A1 was added
gene: ATP2A1 was added to Malignant Hyperthermia Susceptibility. Sources: Literature
Mode of inheritance for gene: ATP2A1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: ATP2A1 were set to 32040565
Phenotypes for gene: ATP2A1 were set to Brody myopathy MIM#601003
Review for gene: ATP2A1 was set to AMBER
Added comment: In a study of 40 Brody disease cases, 3 unrelated cases with biallelic variants had positive in vitro contracture tests on muscle biopsy, and 2 of these cases had episode(s) of suspected MH following administration of general anaesthetics. An additional case experienced several episodes of unexplained hyperthermia, but had not undergone IVCT. 8 other cases reported in the cohort have undergone general anaesthesia without any adverse reactions.
Sources: Literature